A research report projects ANGELALIGN (06699) to achieve revenues of $342 million, $406 million, and $478 million for 2025-2027 respectively (compared to previous estimates of $322 million, $383 million, and $453 million), with net profits attributable to shareholders of $12 million, $23 million, and $40 million respectively (versus previous estimates of $12 million, $21 million, and $38 million). The upward revision is attributed to accelerated global expansion, maintaining a "buy" rating. On August 25, the company released its 2025 interim report. In H1 2025, the company achieved revenue of $161 million, up 33.1% year-over-year, with net profit attributable to shareholders reaching $14.643 million, surging 364.25% year-over-year. Operating cash flow totaled $17.535 million, increasing 196.72% year-over-year.